Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity
Titel:
Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity
Auteur:
Elamin, Yasir Y. Robichaux, Jacqulyne P. Carter, Brett W. Altan, Mehmet Tran, Hai Gibbons, Don L. Heeke, Simon Fossella, Frank V. Lam, Vincent K. Le, Xiuning Negrao, Marcelo V. Nilsson, Monique B. Patel, Anisha Vijayan, R.S.K. Cross, Jason B. Zhang, Jianjun Byers, Lauren A. Lu, Charles Cascone, Tina Feng, Lei Luthra, Rajyalakshmi San Lucas, Francis A. Mantha, Geeta Routbort, Mark Blumenschein Jr., George Tsao, Anne S. Heymach, John V.